142 related articles for article (PubMed ID: 9570569)
21. Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice.
Stolp J; Chen YG; Cox SL; Henck V; Zhang W; Tsaih SW; Chapman H; Stearns T; Serreze DV; Silveira PA
J Immunol; 2012 Aug; 189(3):1406-17. PubMed ID: 22732593
[TBL] [Abstract][Full Text] [Related]
22. [Current studies on the identification of susceptibility genes for IDDM in NOD mice].
Miyazaki J; Ishii M; Tashiro F
Nihon Rinsho; 1994 Oct; 52(10):2772-7. PubMed ID: 7983813
[TBL] [Abstract][Full Text] [Related]
23. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.
Lee CH; Chen YG; Chen J; Reifsnyder PC; Serreze DV; Clare-Salzler M; Rodriguez M; Wasserfall C; Atkinson MA; Leiter EH
Diabetes; 2006 Jan; 55(1):171-8. PubMed ID: 16380490
[TBL] [Abstract][Full Text] [Related]
24. The NOD allele of the Idd5 locus on chromosome 1 mediates a non-cell-autonomous defect in negative selection of T cells.
Motta V; Lejon K; Holmberg D
J Autoimmun; 2007 Jun; 28(4):216-23. PubMed ID: 17449224
[TBL] [Abstract][Full Text] [Related]
25. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping.
Ikegami H; Makino S; Yamato E; Kawaguchi Y; Ueda H; Sakamoto T; Takekawa K; Ogihara T
J Clin Invest; 1995 Oct; 96(4):1936-42. PubMed ID: 7560085
[TBL] [Abstract][Full Text] [Related]
26. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
27. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
Chen YG; Scheuplein F; Osborne MA; Tsaih SW; Chapman HD; Serreze DV
Diabetes; 2008 Dec; 57(12):3273-80. PubMed ID: 18776136
[TBL] [Abstract][Full Text] [Related]
28. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.
Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM
J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
Johnson EA; Silveira P; Chapman HD; Leiter EH; Serreze DV
J Immunol; 2001 Aug; 167(4):2404-10. PubMed ID: 11490031
[TBL] [Abstract][Full Text] [Related]
30. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
[TBL] [Abstract][Full Text] [Related]
31. The Idd13 congenic interval defines the number of merocytic dendritic cells, a novel trait associated with autoimmune diabetes susceptibility.
Pelletier AN; Lesage S
J Autoimmun; 2013 Jun; 43():70-7. PubMed ID: 23623717
[TBL] [Abstract][Full Text] [Related]
32. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice.
Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537
[TBL] [Abstract][Full Text] [Related]
33. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
34. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.
Hattori M; Yamato E; Itoh N; Senpuku H; Fujisawa T; Yoshino M; Fukuda M; Matsumoto E; Toyonaga T; Nakagawa I; Petruzzelli M; McMurray A; Weiner H; Sagai T; Moriwaki K; Shiroishi T; Maron R; Lund T
J Immunol; 1999 Aug; 163(4):1721-4. PubMed ID: 10438898
[TBL] [Abstract][Full Text] [Related]
35. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene.
Serreze DV; Prochazka M; Reifsnyder PC; Bridgett MM; Leiter EH
J Exp Med; 1994 Oct; 180(4):1553-8. PubMed ID: 7931087
[TBL] [Abstract][Full Text] [Related]
36. Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.
Chen YG; Driver JP; Silveira PA; Serreze DV
Immunogenetics; 2007 Sep; 59(9):705-12. PubMed ID: 17619875
[TBL] [Abstract][Full Text] [Related]
37. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.
Fox CJ; Paterson AD; Mortin-Toth SM; Danska JS
Am J Hum Genet; 2000 Jul; 67(1):67-81. PubMed ID: 10848492
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.
Serreze DV; Leiter EH; Christianson GJ; Greiner D; Roopenian DC
Diabetes; 1994 Mar; 43(3):505-9. PubMed ID: 8314025
[TBL] [Abstract][Full Text] [Related]
39. A non-MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes-Prone rat.
Yokoi N; Kanazawa M; Kitada K; Tanaka A; Kanazawa Y; Suda S; Ito H; Serikawa T; Komeda K
J Clin Invest; 1997 Oct; 100(8):2015-21. PubMed ID: 9329965
[TBL] [Abstract][Full Text] [Related]
40. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice.
Silveira PA; Chapman HD; Stolp J; Johnson E; Cox SL; Hunter K; Wicker LS; Serreze DV
J Immunol; 2006 Nov; 177(10):7033-41. PubMed ID: 17082619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
